An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients with Hepatic Dominant Ocular Melanoma
Clinical Trial Grant
Awarded By
Delcath Systems, Inc.
Start Date
August 30, 2022
End Date
June 17, 2025
Awarded By
Delcath Systems, Inc.
Start Date
August 30, 2022
End Date
June 17, 2025